N-acetyltransferase 1 genetic polymorphism, cigarette smoking, well-done meat intake, and breast cancer risk.

N-Acetyltransferase 1 (NAT1), encoded by the polymorphic NAT1 gene, has been shown to be one of the major enzymes in human breast tissue that activates aromatic and heterocyclic amines. Humans are mainly exposed to these carcinogens through cigarette smoking and consumption of well-done meat. To test the hypothesis that variations in the NAT1 gene are related to breast cancer risk, particularly among women who smoke or consume high levels of well-done meat, a nested case-control study was conducted in a prospective cohort study of 41,837 postmenopausal Iowa women. Information on cigarette smoking and other breast cancer risk factors was obtained at the baseline survey conducted in 1986. DNA samples and information on the consumption of well-done meat were obtained, in the case-control study, from breast cancer cases diagnosed from 1992 to 1994 and a random sample of cancer-free cohort members. Genomic DNA samples obtained from 154 cases and 330 controls were assayed for 11 NAT1 alleles (NAT1*3, *4, *5, *10, *11, *14, *15, *16, *17, *19, and *22). The NAT1*4 allele was the predominant allele observed in this study population, accounting for 73.2% (72.4% in cases versus 73.8% in controls) of the total alleles analyzed. Compared to controls, breast cancer cases had a slightly higher frequency of the NAT1*10 allele (18.8% in cases versus 17.3% in controls) and a substantially higher frequency of the NAT1*11 allele (3.6% versus 1.2%). In multivariate analyses, we found a 30% [95% confidence interval (CI) = 0.8-1.9] elevated risk of breast cancer associated with the NAT1*10 allele and a nearly 4-fold (95% CI = 1.5-10.5) elevated risk associated with the NAT1*11 allele. The positive association of breast cancer with the NAT1*11 allele was more evident among smokers [odds ratio (OR) = 13.2, 95% CI = 1.5-116.0] and those who consumed a high level of red meat (OR = 6.1, 95% CI = 1.1-33.2) or consistently consumed their red meat well done (OR = 5.6, 95% CI = 0.5-62.7). The association of the NAT1*10 allele with breast cancer was mainly confined to former smokers (OR = 3.3, 95% CI = 1.2-9.5). These findings are consistent with a role for the NAT1 gene in the etiology of human breast cancer.

[1]  J. Cerhan,et al.  Well-done meat intake and the risk of breast cancer. , 1998, Journal of the National Cancer Institute.

[2]  N. Probst-Hensch,et al.  Variants of N-acetyltransferase NAT1 and a case-control study of colorectal adenomas. , 1998, Pharmacogenetics.

[3]  O. Olopade,et al.  Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genes. , 1998, Journal of the National Cancer Institute.

[4]  R. Millikan,et al.  Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[5]  G. Fakis,et al.  Expression of arylamine N-acetyltransferase in human intestine , 1998, Gut.

[6]  S. Z. Abdel‐Rahman,et al.  Association of the NAT1*10 genotype with increased chromosome aberrations and higher lung cancer risk in cigarette smokers. , 1998, Mutation research.

[7]  D. Grant,et al.  Identification and characterization of variant alleles of human acetyltransferase NAT1 with defective function using p-aminosalicylate as an in-vivo and in-vitro probe. , 1998, Pharmacogenetics.

[8]  R. Minchin,et al.  Functional polymorphism of the human arylamine N-acetyltransferase type 1 gene caused by C190T and G560A mutations. , 1998, Pharmacogenetics.

[9]  A. Deitz,et al.  A restriction fragment length polymorphism assay that differentiates human N-acetyltransferase-1 (NAT1) alleles. , 1997, Analytical biochemistry.

[10]  J. Manson,et al.  A prospective study of NAT2 acetylation genotype, cigarette smoking, and risk of breast cancer. , 1997, Carcinogenesis.

[11]  A. Ronco,et al.  Meat intake, heterocyclic amines, and risk of breast cancer: a case-control study in Uruguay. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[12]  R. Sinha,et al.  Exposure assessment of heterocyclic amines (HCAs) in epidemiologic studies. , 1997, Mutation research.

[13]  D. Grant,et al.  Human acetyltransferase polymorphisms. , 1997, Mutation research.

[14]  J. Potter,et al.  Metabolic activation of aromatic amines by human pancreas. , 1997, Carcinogenesis.

[15]  T. Rustan,et al.  Identification of a novel allele at the human NAT1 acetyltransferase locus. , 1997, Biochemical and biophysical research communications.

[16]  J. Freudenheim,et al.  Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. , 1996, JAMA.

[17]  C. Davis,et al.  N-acetyltransferase expression and metabolic activation of the food-derived heterocyclic amines in the human mammary gland. , 1996, Cancer research.

[18]  M. Bernstein,et al.  Relation of breast cancer with passive and active exposure to tobacco smoke. , 1996, American journal of epidemiology.

[19]  D. Bell,et al.  Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder. , 1995, Cancer research.

[20]  D. Bell,et al.  Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation signal: association of NAT1*10 allele with higher N-acetylation activity in bladder and colon tissue. , 1995, Cancer research.

[21]  D. Bell,et al.  Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer. , 1995, Cancer research.

[22]  T. Rustan,et al.  Metabolic activation of N-hydroxyarylamines and N-hydroxyarylamides by 16 recombinant human NAT2 allozymes: effects of 7 specific NAT2 nucleic acid substitutions. , 1995, Cancer research.

[23]  M. Relling,et al.  Nomenclature for N-acetyltransferases. , 1995, Pharmacogenetics.

[24]  K T Bogen,et al.  Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research. , 1995, Carcinogenesis.

[25]  N Ito,et al.  Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in rats: dose-response studies. , 1995, Princess Takamatsu symposia.

[26]  G. Steineck,et al.  Intake of fried meat and risk of cancer: A follow‐up study in finland , 1994, International journal of cancer.

[27]  P. Vineis.  Epidemiology of cancer from exposure to arylamines. , 1994, Environmental health perspectives.

[28]  T. Ushijima,et al.  Dietary carcinogens and mammary carcinogenesis. Induction of rat mammary carcinomas by administration of heterocyclin amines in cooked foods , 1994, Cancer.

[29]  T. Sellers,et al.  Mortality and cancer rates in nonrespondents to a prospective study of older women: 5-year follow-up. , 1994, American journal of epidemiology.

[30]  R. Minchin,et al.  Role of acetylation in colorectal cancer. , 1993, Mutation research.

[31]  D. Grant,et al.  Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases. , 1993, Carcinogenesis.

[32]  J. Weisburger.  Heterocyclic amines in cooked foods: possible human carcinogens. , 1993, Cancer research.

[33]  W. Weber,et al.  Structural heterogeneity of Caucasian N-acetyltransferase at the NAT1 gene locus. , 1993, Archives of biochemistry and biophysics.

[34]  J. Cerhan,et al.  Body fat distribution and 5-year risk of death in older women. , 1993, JAMA.

[35]  J. Palmer,et al.  Cigarette smoking and the risk of breast cancer. , 1993, Epidemiologic reviews.

[36]  T. Sellers,et al.  Dietary fat and postmenopausal breast cancer. , 1992, Journal of the National Cancer Institute.

[37]  R. Minchin,et al.  N-and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferases expressed in COS-1 cells. , 1992, Biochemical and biophysical research communications.

[38]  N Ito,et al.  A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). , 1991, Carcinogenesis.

[39]  H. Ohgaki,et al.  Carcinogenicities of heterocyclic amines in cooked food. , 1991, Mutation research.

[40]  D. Thomas,et al.  Breast cancer in Argentina: case-control study with special reference to meat eating habits. , 1991, Neoplasma.

[41]  J. Kaldor,et al.  A case‐control study of diet and breast cancer in Argentina , 1989, International journal of cancer.

[42]  J. Baron,et al.  Cigarette smoking and breast cancer. , 1989, American journal of epidemiology.

[43]  D. Hein.  Acetylator genotype and arylamine-induced carcinogenesis. , 1988, Biochimica et biophysica acta.

[44]  G. Williams,et al.  Mutagens and carcinogens formed during cooking. , 1986, Advances in experimental medicine and biology.

[45]  W. Weber,et al.  N-acetylation pharmacogenetics. , 1985, Pharmacological reviews.

[46]  R. Phillips.  Role of life-style and dietary habits in risk of cancer among seventh-day adventists. , 1975, Cancer research.